| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
53,520,000 |
| Market
Cap: |
36.18(M) |
| Last
Volume: |
446,593 |
Avg
Vol: |
445,379 |
| 52
Week Range: |
$0.676 - $0.676 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
386,399 |
680,912 |
680,912 |
680,912 |
| Total Buy Value |
$353,333 |
$620,149 |
$620,149 |
$620,149 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
28 |
40 |
40 |
40 |
| Total Shares Sold |
0 |
0 |
30,110 |
30,110 |
| Total Sell Value |
$0 |
$0 |
$26,460 |
$26,460 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
5 |
5 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyd Steven |
10% Owner |
– – • |
2018-06-21 |
4 |
B |
$1.25 |
$176 |
D/D |
140 |
3,017,584 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-20 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
3,017,444 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-20 |
4 |
B |
$1.27 |
$4,685 |
D/D |
3,702 |
3,017,444 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-18 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
3,013,742 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-18 |
4 |
B |
$1.20 |
$16,532 |
D/D |
13,742 |
3,013,742 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-14 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
3,000,000 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-14 |
4 |
B |
$1.15 |
$33,521 |
D/D |
29,103 |
3,000,000 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-13 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,970,897 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-13 |
4 |
B |
$1.07 |
$154,741 |
D/D |
145,297 |
2,970,897 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-12 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,825,600 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-12 |
4 |
B |
$1.08 |
$188,532 |
D/D |
156,895 |
2,825,600 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-11 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,668,705 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-06-11 |
4 |
B |
$1.18 |
$436,055 |
D/D |
368,705 |
2,668,705 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-01-22 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
2,300,000 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-01-22 |
4 |
B |
$1.42 |
$143,025 |
D/D |
100,000 |
2,300,000 |
2.45 |
- |
|
| Merton Robert C |
Director |
– • – |
2017-11-10 |
4 |
B |
$1.75 |
$149,975 |
D/D |
85,700 |
95,451 |
2.39 |
- |
|
| Mammen Mammen |
Sr VP, Clinical DevelopmentOff |
• – – |
2017-05-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,399 |
|
- |
|
| Ramos Anthony Alan |
VP, Chief Accounting Officer |
• – – |
2017-03-27 |
4 |
AS |
$2.17 |
$9,240 |
D/D |
(4,250) |
9,674 |
|
- |
|
| Smith Lawrence Russell |
VP, Vaccine Research |
• – – |
2017-03-15 |
4 |
AS |
$2.31 |
$2,021 |
D/D |
(875) |
17,696 |
|
- |
|
| Samant Vijay B |
President & CEO |
• • – |
2017-02-01 |
4 |
AS |
$2.16 |
$8,088 |
D/D |
(3,750) |
87,420 |
|
- |
|
| Smith Lawrence Russell |
VP, Vaccine Research |
• – – |
2017-01-11 |
4 |
AS |
$2.48 |
$134 |
D/D |
(54) |
23,071 |
|
- |
|
| Samant Vijay B |
President & CEO |
• • – |
2017-01-10 |
4 |
AS |
$2.45 |
$14,114 |
D/D |
(5,763) |
91,170 |
|
- |
|
| Merton Robert C |
Director |
– • – |
2016-12-22 |
4 |
S |
$2.26 |
$4,520 |
D/D |
(2,000) |
9,751 |
|
- |
|
| Merton Robert C |
Director |
– • – |
2016-12-21 |
4 |
S |
$2.22 |
$4,440 |
D/D |
(2,000) |
11,751 |
|
- |
|
| Merton Robert C |
Director |
– • – |
2016-12-20 |
4 |
S |
$2.22 |
$4,440 |
D/D |
(2,000) |
13,751 |
|
- |
|
583 Records found
|
|
Page 8 of 24 |
|
|
